Ceretec Stabilised vs Macrosalb Medi Radiopharma: Side-by-Side Comparison
Quick answer: Ceretec Stabilised and Macrosalb Medi Radiopharma are both radiopharmaceutical diagnostic agent used for similar indications. They share a mechanism of action but differ in dosing, half-life, side-effect profile, and clinical preferences. Switching between them is a clinical decision.
Side-by-side comparison
| Feature | Ceretec Stabilised | Macrosalb Medi Radiopharma |
|---|---|---|
| Drug class | Radiopharmaceutical diagnostic agent | Radiopharmaceutical diagnostic agent |
| ATC code | V09AA01 | V09EB01 |
| Primary indications | Cerebral perfusion SPECT imaging, Leukocyte labelling for infection/inflammation imaging | Lung perfusion scintigraphy, Pulmonary embolism diagnosis |
| Mechanism | Technetium-99m exametazime (HMPAO) — lipophilic chelate that crosses the blood-brain barrier and is retained in brain tissue proportional to regional perfusion | Technetium-99m labeled albumin macroaggregates lodge in pulmonary capillaries for perfusion imaging |
| Common dose | 370-1110 MBq IV depending on indication | Diagnostic activity 40-150 MBq IV |
| Detail page | Ceretec Stabilised details → | Macrosalb Medi Radiopharma details → |
How to choose between Ceretec Stabilised and Macrosalb Medi Radiopharma
Both medicines belong to the same therapeutic class and address overlapping indications. Selection between them depends on:
- Patient-specific factors: age, kidney and liver function, other medications, allergies, comorbidities
- Specific clinical indication: some class members are preferred for particular conditions or guideline recommendations
- Dosing preference: once-daily vs twice-daily, oral vs injectable, food requirements
- Tolerability: individual side-effect profiles vary even within a class
- Drug interactions: patient's other medications may interact differently with each option
- Cost and availability: generic availability, insurance coverage, regional access
Should you switch?
Switching between class members is a clinical decision, not a self-help one. Reasons your prescriber may consider switching include:
- Inadequate response to current medication
- Side effects affecting quality of life
- New drug interactions due to a recently added medication
- Cost or availability changes
- Updated guidelines favoring a different option
Never switch medications, change dose, or stop without consulting your prescriber.
Related
All Radiopharmaceutical diagnostic agent on iMedic · Ceretec Stabilised full details · Macrosalb Medi Radiopharma full details
Frequently asked questions
Is Ceretec Stabilised better than Macrosalb Medi Radiopharma?
Neither is universally 'better.' They are both radiopharmaceutical diagnostic agent with similar mechanisms of action. The right choice depends on the specific clinical situation, patient factors, dosing preferences, drug interactions, and tolerability. Discuss with your prescriber.
Can I switch from Ceretec Stabilised to Macrosalb Medi Radiopharma?
Switching is possible but should be done under clinical supervision. Different class members may not be interchangeable on a 1:1 dose basis, and tapering or transition strategies vary. Never switch on your own.
Do Ceretec Stabilised and Macrosalb Medi Radiopharma have the same side effects?
They share class-wide side-effect tendencies but differ in individual profiles. Some patients tolerate one better than the other. Specific frequency and severity of side effects can be found on each medicine's individual page.
Are Ceretec Stabilised and Macrosalb Medi Radiopharma available as generics?
Generic availability depends on patent status in your country. Most well-established class members are available generically and are clinically equivalent to brand-name versions.
Last reviewed: by iMedic Medical Editorial Team. Our editorial process.